{"database": "lobbying", "table": "lobbying_activities", "rows": [[2772482, "b9f69c38-63e2-4c4a-8370-231610804ab0", "Q1", "THE NICKLES GROUP, LLC", 293335, "AMGEN", 2022, "first_quarter", "MMM", "H.R. 5376, The Build Better Back Act and issues regarding drug pricing. Issues regarding ESRD payments. H.R. 3517 / S. 1943, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2022-04-12T17:46:48-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2772482"], "units": {}, "query_ms": 1.2067589996149763, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}